Late-stage pipeline drugs could compete with only treatment for SMA
A number of drugs currently in their late stages in the development process could see competition for nusinersen, the only current SMA treatment, rise...
List view / Grid view
A number of drugs currently in their late stages in the development process could see competition for nusinersen, the only current SMA treatment, rise...
Infants with SMA are more likely to show gains in motor function and survive without assisted support when treated with nusinersen...